Glossary entry (derived from question below)
Spanish term or phrase:
quelantes cálcicos versus los no cálcicos
English translation:
calcium-based phosphate binders vs. non-calcium-based phosphate binders
Added to glossary by
liz askew
Feb 11, 2013 17:05
11 yrs ago
1 viewer *
Spanish term
Spain
... a question of style.
Native in: English (Variant: UK) 
, Spanish (Variant: Standard-Spain) 
Works in: Spanish to English, English to Spanish, English, and 1 more.
quelantes cálcicos versus los no cálcicos
Spanish to English
Medical
Medical (general)
Nephrology
This appears in a questionnaire regarding nephrology.
Any help is appreciated.
TIA.
Any help is appreciated.
TIA.
Proposed translations
(English)
| 4 +2 | phospate binders vs. non-phosphate binders |
liz askew
|
| 4 +1 | calcium ve. non-calcium chelators |
Lafayette Eaton
|
| 2 | non-/calcium-containing binders |
Sebastian Wasserzug
|
Change log
Feb 14, 2013 17:53: liz askew changed "Edited KOG entry" from "<a href="/profile/1284757">Andrew Darling's</a> old entry - "quelantes cálcicos versus los no cálcicos"" to ""calcium-based phosphate binders vs. non-calcium-based phosphate binders""
Proposed translations
+2
2 hrs
Selected
phospate binders vs. non-phosphate binders
Quelante de fosfato - Wikipedia, la enciclopedia libre
es.wikipedia.org/wiki/Quelante_de_fosfato - Translate this page
Los quelante de fosfato son un grupo de medicamentos quelantes que son tomados ... American Association of Kidney Patients*; Phosphate Binders - National ...
--------------------------------------------------
Note added at 2 hrs (2013-02-11 19:18:19 GMT)
--------------------------------------------------
http://www.fmc-ag.com/3179.htm
June 23, 2010
Based on data from its recently completed CALMAG (CALcium acetate MAGnesium carbonate evaluation) study, Fresenius Medical Care is announcing a demonstration of the effectiveness of its combined phosphate binder OsvaRen® (calcium acetate/magnesium carbonate) in the treatment of hyperphosphatemia in hemodialysis patients. A scientific symposium unveiling these findings will take place during the 2010 European Dialysis and Transplant Association (EDTA) congress in Munich, Germany (June 25-28).
--------------------------------------------------
Note added at 2 hrs (2013-02-11 19:20:12 GMT)
--------------------------------------------------
Phosphate binder - Wikipedia, the free encyclopedia
en.wikipedia.org/wiki/Phosphate_binder
Phosphate binders are a group of medications used to reduce the absorption of ... Renvela); Calcium acetate/magnesium carbonate (Renepho, OsvaRen) ...
--------------------------------------------------
Note added at 2 hrs (2013-02-11 19:21:42 GMT)
--------------------------------------------------
see here regarding "binders"
http://survivinghealthcareattheuhn.wordpress.com/tag/osvaren...
--------------------------------------------------
Note added at 2 hrs (2013-02-11 19:22:52 GMT)
--------------------------------------------------
Strictly speaking
calcium-containing phosphate binders vs. non-calcium containing phosphate binders
Health Economics Review | Full text | Considerations about the ...
www.healtheconomicsreview.com/content/1/1/1
by T Plagemann - 2011 - Related articles
The results of this systematic review showed that OsvaRen® is at least equally effective .... In contrast, the authors found that calcium-based phosphate binders, ...
[PDF]
Osvaren - Scottish Medicines Consortium
www.scottishmedicines.org.uk/.../calcium_acetate_and_magnes...
File Format: PDF/Adobe Acrobat - Quick View
Apr 11, 2011 – Osvaren is a fixed dose oral formulation of calcium acetate ... insufficiently controlled by calcium-containing phosphate binders .... strategy may delay movement to more expensive non-calcium based phosphate binders, no ...
es.wikipedia.org/wiki/Quelante_de_fosfato - Translate this page
Los quelante de fosfato son un grupo de medicamentos quelantes que son tomados ... American Association of Kidney Patients*; Phosphate Binders - National ...
--------------------------------------------------
Note added at 2 hrs (2013-02-11 19:18:19 GMT)
--------------------------------------------------
http://www.fmc-ag.com/3179.htm
June 23, 2010
Based on data from its recently completed CALMAG (CALcium acetate MAGnesium carbonate evaluation) study, Fresenius Medical Care is announcing a demonstration of the effectiveness of its combined phosphate binder OsvaRen® (calcium acetate/magnesium carbonate) in the treatment of hyperphosphatemia in hemodialysis patients. A scientific symposium unveiling these findings will take place during the 2010 European Dialysis and Transplant Association (EDTA) congress in Munich, Germany (June 25-28).
--------------------------------------------------
Note added at 2 hrs (2013-02-11 19:20:12 GMT)
--------------------------------------------------
Phosphate binder - Wikipedia, the free encyclopedia
en.wikipedia.org/wiki/Phosphate_binder
Phosphate binders are a group of medications used to reduce the absorption of ... Renvela); Calcium acetate/magnesium carbonate (Renepho, OsvaRen) ...
--------------------------------------------------
Note added at 2 hrs (2013-02-11 19:21:42 GMT)
--------------------------------------------------
see here regarding "binders"
http://survivinghealthcareattheuhn.wordpress.com/tag/osvaren...
--------------------------------------------------
Note added at 2 hrs (2013-02-11 19:22:52 GMT)
--------------------------------------------------
Strictly speaking
calcium-containing phosphate binders vs. non-calcium containing phosphate binders
Health Economics Review | Full text | Considerations about the ...
www.healtheconomicsreview.com/content/1/1/1
by T Plagemann - 2011 - Related articles
The results of this systematic review showed that OsvaRen® is at least equally effective .... In contrast, the authors found that calcium-based phosphate binders, ...
[PDF]
Osvaren - Scottish Medicines Consortium
www.scottishmedicines.org.uk/.../calcium_acetate_and_magnes...
File Format: PDF/Adobe Acrobat - Quick View
Apr 11, 2011 – Osvaren is a fixed dose oral formulation of calcium acetate ... insufficiently controlled by calcium-containing phosphate binders .... strategy may delay movement to more expensive non-calcium based phosphate binders, no ...
Peer comment(s):
| agree |
David Brown
: Although you are nearer the mark, we translate not dictate---http://www.medscape.com/viewarticle/542490_3
23 hrs
|
|
sure thing: but we translate so that an English audience understands, and we use the terminology of the experts, as much as we are able to:)
|
|
| agree |
Muriel Vasconcellos
1 day 5 hrs
|
2 KudoZ points awarded for this answer.
Comment: "Thanks very much for your answer :) "
+1
26 mins
Lafayette Eaton
Chile
Chile
Native in English
Works in field
Chile
Ph.D Genetics, translations/ed. reviews
Native in: English (Variant: US)
Works in: Spanish to English
Related KudoZ points
:
6
calcium ve. non-calcium chelators
Some chelating agents involve calcium, others do not.
Peer comment(s):
| agree |
David Brown
: This is nearer"calcium versus non- calcium based binders" A while back I would have used the phrase "chelating agents", but that's physical chemistry for you
1 day 1 hr
|
49 mins
Sebastian Wasserzug
Argentina
Argentina
Native in Spanish
Specializes in field
Argentina
Accurate, fluent & eloquent
Native in: Spanish (Variant: Latin American)
Works in: English to Spanish, Spanish to English
Related KudoZ points
:
4
non-/calcium-containing binders
Another option.
Chalation seems to be the phenomenon of the ions and molecules "binding" metal ions... But I am no quite sure what's the most common usage.
Chalation seems to be the phenomenon of the ions and molecules "binding" metal ions... But I am no quite sure what's the most common usage.
Peer comment(s):
| neutral |
liz askew
: believe it or not I did not see your entry for "binders"; apologies, but I feel my answer may be more complete.
1 hr
|
Reference comments
2 hrs
Reference:
see
The reason I said it was “fishy” was because I could find nothing reliable for “calcium-based/calcium chelators/chelating agent” with regard to nephrology and dialysis
https://docs.google.com/viewer?a=v&q=cache:3uwd5Wkm_kAJ:scie...
there are different types of “quelantes”
1)quelantes cálcicos
Carbonato cálcico
Acetato cálcico ((Royen)
Carbonato de magnesio + acetato cálcico (Osvaren)
2) Quelantes metálicos
3) Quelantes no cálcicos y no metálicos
European Peritoneal Dialysis Meeting 2011 - EuroPD
www.europd.com/upload/.../europd_2011_book_of_abstracts.pdf
File Format: PDF/Adobe Acrobat
entered the combination of magnesium carbonate + calcium acetate. ... 1.25 mmol / L who has chwww.revistanefrologia.com/revistas/P1-E534/P1-E534-EN.pdf
File Format: PDF/Adobe Acrobat
Calcium carbonate. Calcium acetate (Royen®). Calcium acetate/magnesium carbonate (Osvaren®). 2) Metal-based binders. Aluminium. Lanthanum (Fosrenol®) .anged the calcium acetate (Royen ®) ® Osvaren initially with a ...
http://www.scottishmedicines.org.uk/SMC_Advice/Advice/693_11...
SMC did not accept calcium acetate and magnesium carbonate tablet for the treatment of hyperphosphataemia associated with chronic renal insufficiency in patients undergoing dialysis (haemodialysis, peritoneal dialysis).
• Patients whose kidneys have failed often have unusually high levels of a chemical called phosphate in the blood, leading to a metabolic disorder called hyperphosphataemia. This condition can lead to bone disease, joint problems and heart disease. Haemodialysis and peritoneal dialysis are treatments for kidney failure which use alternative methods to replace the function of the kidneys.
• Treatment for hyperphosphataemia involves the use of medicines known as ****phosphate binders. Calcium acetate and magnesium carbonate are phosphate binders which prevent the phosphate in food from being absorbed into the bloodstream****. The tablet is taken 3–12 times a day with meals.
• SMC did not accept the following medicines for NHSScotland.
• A study has shown that calcium acetate and magnesium carbonate reduces hyperphosphataemia in patients with chronic kidney disease as effectively as another phosphate binder.
• Side effects of calcium acetate and magnesium carbonate were similar to those of another phosphate binder.
• SMC did not accept calcium acetate and magnesium carbonate tablet for use in NHSScotland as there were a number of weaknesses in the economic case prepared by the manufacturer which meant the medicine did not offer value for money.
https://docs.google.com/viewer?a=v&q=cache:3uwd5Wkm_kAJ:scie...
there are different types of “quelantes”
1)quelantes cálcicos
Carbonato cálcico
Acetato cálcico ((Royen)
Carbonato de magnesio + acetato cálcico (Osvaren)
2) Quelantes metálicos
3) Quelantes no cálcicos y no metálicos
European Peritoneal Dialysis Meeting 2011 - EuroPD
www.europd.com/upload/.../europd_2011_book_of_abstracts.pdf
File Format: PDF/Adobe Acrobat
entered the combination of magnesium carbonate + calcium acetate. ... 1.25 mmol / L who has chwww.revistanefrologia.com/revistas/P1-E534/P1-E534-EN.pdf
File Format: PDF/Adobe Acrobat
Calcium carbonate. Calcium acetate (Royen®). Calcium acetate/magnesium carbonate (Osvaren®). 2) Metal-based binders. Aluminium. Lanthanum (Fosrenol®) .anged the calcium acetate (Royen ®) ® Osvaren initially with a ...
http://www.scottishmedicines.org.uk/SMC_Advice/Advice/693_11...
SMC did not accept calcium acetate and magnesium carbonate tablet for the treatment of hyperphosphataemia associated with chronic renal insufficiency in patients undergoing dialysis (haemodialysis, peritoneal dialysis).
• Patients whose kidneys have failed often have unusually high levels of a chemical called phosphate in the blood, leading to a metabolic disorder called hyperphosphataemia. This condition can lead to bone disease, joint problems and heart disease. Haemodialysis and peritoneal dialysis are treatments for kidney failure which use alternative methods to replace the function of the kidneys.
• Treatment for hyperphosphataemia involves the use of medicines known as ****phosphate binders. Calcium acetate and magnesium carbonate are phosphate binders which prevent the phosphate in food from being absorbed into the bloodstream****. The tablet is taken 3–12 times a day with meals.
• SMC did not accept the following medicines for NHSScotland.
• A study has shown that calcium acetate and magnesium carbonate reduces hyperphosphataemia in patients with chronic kidney disease as effectively as another phosphate binder.
• Side effects of calcium acetate and magnesium carbonate were similar to those of another phosphate binder.
• SMC did not accept calcium acetate and magnesium carbonate tablet for use in NHSScotland as there were a number of weaknesses in the economic case prepared by the manufacturer which meant the medicine did not offer value for money.
Discussion